GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Simris Alg AB (OSTO:SIMRIS B) » Definitions » EBITDA Margin %

Simris Alg AB (OSTO:SIMRIS B) EBITDA Margin % : -327.50% (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Simris Alg AB EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Simris Alg AB's EBITDA for the three months ended in Dec. 2024 was kr-3.18 Mil. Simris Alg AB's Revenue for the three months ended in Dec. 2024 was kr0.97 Mil. Therefore, Simris Alg AB's EBITDA margin for the quarter that ended in Dec. 2024 was -327.50%.


Simris Alg AB EBITDA Margin % Historical Data

The historical data trend for Simris Alg AB's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simris Alg AB EBITDA Margin % Chart

Simris Alg AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -954.02 -357.24 -441.30 -513.69 -608.75

Simris Alg AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -203.35 -1,026.01 -964.83 -387.86 -327.50

Competitive Comparison of Simris Alg AB's EBITDA Margin %

For the Biotechnology subindustry, Simris Alg AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simris Alg AB's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Simris Alg AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Simris Alg AB's EBITDA Margin % falls into.


;
;

Simris Alg AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Simris Alg AB's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-17.593/2.89
=-608.75 %

Simris Alg AB's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-3.18/0.971
=-327.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Simris Alg AB  (OSTO:SIMRIS B) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Simris Alg AB EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Simris Alg AB's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Simris Alg AB Business Description

Traded in Other Exchanges
Address
Herrestadsvagen 24A, Hammenhog, SWE, 276 50
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.

Simris Alg AB Headlines

No Headlines